In summary, this work demonstrated that indisulam inhibits the migration of gastric cancer cells through degrading the transcription factor ZEB1 and regulating the downstream EMT process, suggesting that indisulam may exhibit antimetastatic activity in gastric cancer. The gene discussed is ZEB1; the disease is gastric cancer.